According to the American Cancer Society, this year, 1,918,030 new cancer diagnoses and 609,360 cancer deaths are projected to occur in the United States. This article from the Michigan Medicine Health Blog highlights the researchers at the U-M Rogel Cancer Center who are leading the charge in finding the molecular mechanisms behind cancer and working to help individuals lead a longer and better quality of life in the future. Eric Fearon, M.D., Ph.D., the Emanuel N. Maisel professor of oncology and the Rogel Cancer Center director, discusses what happens before, during, and after a cancer diagnosis with a molecular approach.
